CD Genomics Highlights RNA Sequencing Services for Transcript Discovery and Isoform-Level Research

CD Genomics is highlighting its RNA sequencing services for researchers seeking flexible tools for transcriptome analysis, gene expression profiling, and full-length transcript characterization. The service is designed to support the analysis of gene expression patterns, transcriptome changes, and the detection of novel RNA molecules, mutations, and gene fusions, giving research teams a broader view of RNA biology across different study designs.

A key strength of the offering lies in its breadth. Rather than limiting researchers to a single sequencing workflow, CD Genomics provides multiple RNA-seq options to accommodate different sample types, input amounts, and research goals. This allows scientists to select a more suitable strategy for each project instead of forcing diverse RNA studies into a one-size-fits-all approach.

Through its advanced transcriptome profiling and RNA analysis services, CD Genomics supports projects ranging from routine gene expression studies to more complex transcript discovery work. The service is positioned to help researchers investigate transcript diversity, identify RNA variants, and gain clearer insight into transcript structure in studies where standard approaches may not be enough.

Another point of differentiation is the company’s support for long-read Iso-Seq alongside conventional next-generation sequencing workflows. This gives researchers an option for full-length transcript sequencing and isoform-level analysis, which can be especially valuable for studies involving alternative splicing, transcript heterogeneity, and structurally complex RNA targets. By combining short-read and long-read capabilities within the same service area, CD Genomics offers greater flexibility for teams that need both broad transcriptome coverage and deeper transcript resolution.

CD Genomics also emphasizes sequencing quality as part of the value of its RNA sequencing services. According to the company, the service delivers high-quality sequencing data, with at least 80% of bases at Q30 and an average above 90%. That focus on quality is paired with research support intended to help clients generate data that can better support downstream interpretation and decision-making.

The company presents RNA sequencing as part of its broader genomics capabilities, which are described on its main genomics platform. Even so, the RNA sequencing service remains the central focus of this offering, with particular relevance for researchers who need a service flexible enough to support transcriptome-wide surveys, mutation and fusion analysis, and isoform-focused studies within one research framework.

“RNA research often requires more than a standard sequencing workflow,” said a spokesperson for CD Genomics. “Our RNA sequencing services are designed to give researchers flexible options that align with sample characteristics, project goals, and the level of transcript detail they need.”